R. Wolfram

发表

Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results.

R. Pötter, R. Wolfram, B. Pokrajac, 2001, Radiology.

Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.

H. Brewer, K. Kent, A. Pichard, 2006, The American journal of cardiology.

Repeat Intracoronary Radiation for Recurrent In-Stent Restenosis in Patients Who Failed Intracoronary Radiation

K. Kent, A. Pichard, L. Satler, 2003, Circulation.

Olive phenolics increase glutathione levels in healthy volunteers.

R. Wolfram, F. Visioli, R. Crea, 2009, Journal of agricultural and food chemistry.

Effect of black tea on (iso-)prostaglandins and platelet aggregation in healthy volunteers.

R. Wolfram, H. Sinzinger, A. Budinsky, 2002, Prostaglandins, leukotrienes, and essential fatty acids.

Effects of gamma radiation on the noninjured and unprotected left main

K. Kent, A. Pichard, L. Satler, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Use of restenting should be minimized with intracoronary radiation therapy for in‐stent restenosis

K. Kent, A. Pichard, L. Satler, 2003, Catheterization and cardiovascular interventions.

Comparison of baseline characteristics and one-year outcomes between African-Americans and Caucasians undergoing percutaneous coronary intervention.

A. Pichard, L. Satler, R. Wolfram, 2004, The American journal of cardiology.

Endovascular brachytherapy and late thrombotic occlusion.

R. Wolfram, B. Pokrajac, E. Minar, 2000, Circulation.

Comparison of creatine kinase elevation and outcome of comparison of percutaneous coronary intervention for saphenous vein graft in-stent restenosis versus de novo stenosis.

K. Kent, A. Pichard, L. Satler, 2003, The American journal of cardiology.

Effects of contrast media on porcine bone marrow‐derived mononuclear cells and calf myoblast viability and secretion of VEGF and MCP‐1

S. Epstein, R. Wolfram, R. Pakala, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium.

Elias A. Rivera, R. Virmani, F. Kolodgie, 2004, Cardiovascular radiation medicine.

Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Salivary isoprostanes indicate increased oxidation injury in periodontitis with additional tobacco abuse

R. Wolfram, W. Sperr, H. Sinzinger, 2006, BioFactors.

Narghile (water pipe) smoking influences platelet function and (iso-)eicosanoids.

R. Wolfram, H. Sinzinger, F. Chehne, 2003, Life sciences.

Assessment of peripheral arterial vascular disease with radionuclide techniques.

R. Wolfram, H. Sinzinger, A. Budinsky, 2001, Seminars in nuclear medicine.

Antioxidants attenuate atherosclerotic plaque development in a balloon-denuded and -radiated hypercholesterolemic rabbit.

R. Wolfram, R. Pakala, R. Waksman, 2003, Cardiovascular radiation medicine.

Usefulness of gamma intracoronary radiation for totally occluded in-stent restenotic coronary narrowing.

K. Kent, A. Pichard, L. Satler, 2003, The American journal of cardiology.

The initial course of in-stent restenosis influences the response to vascular brachytherapy.

A. Pichard, L. Satler, R. Wolfram, 2002, Cardiovascular radiation medicine.

Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8‐epi‐PGF2α

R. Wolfram, B. Palumbo, H. Sinzinger, 2005, European journal of heart failure.

Deficiences in phenotype expression and function of dentritic cells from patients with early breast cancer.

R. Wolfram, C. Wiltschke, T. Brodowicz, 2006, European journal of medical research.

Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer

G. Steger, R. Wolfram, T. Brodowicz, 2000, Anti-cancer drugs.

Comparison of effectiveness and safety of three different antithrombotic regimens (bivalirudin, eptifibatide, and heparin) in preventing myocardial ischemia during percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2003, The American journal of cardiology.

(Iso) Prostaglandins in saliva indicate oxidation injury after radioiodine therapy.

R. Wolfram, B. Palumbo, H. Sinzinger, 2004, Revista espanola de medicina nuclear.

Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-segment Elevation who Undergo Percutaneous Coronary Intervention. Results from SWITCH--a multicenter clinical trial.

K. Kent, L. Satler, R. Wolfram, 2006, The Journal of invasive cardiology.

Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Regular ingestion of opuntia robusta lowers oxidation injury.

R. Wolfram, H. Sinzinger, A. Budinsky, 2001, Prostaglandins, leukotrienes, and essential fatty acids.

Clinical long-term results of percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease.

R. Wolfram, R. Ahmadi, R. Bucek, 2002, VASA. Zeitschrift fur Gefasskrankheiten.

Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients.

N. Weissman, K. Kent, A. Pichard, 2006, The Journal of invasive cardiology.

Daily prickly pear consumption improves platelet function.

R. Wolfram, H. Sinzinger, A. Budinsky, 2003, Prostaglandins, leukotrienes, and essential fatty acids.

Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial.

R. Pötter, R. Wolfram, B. Pokrajac, 2005, Radiology.

Effect of prickly pear (Opuntia robusta) on glucose- and lipid-metabolism in non-diabetics with hyperlipidemia--a pilot study.

R. Wolfram, H. Sinzinger, H. Kritz, 2002, Wiener klinische Wochenschrift.

Defect of Tumour Necrosis Factor-α (TNF-α) Production and TNF-α-induced ICAM-1 – Expression in BRCA1 Mutations Carriers

E. Kubista, R. Wolfram, C. Wiltschke, 2003, Breast Cancer Research and Treatment.

Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study.

C. Kirisits, R. Pötter, R. Wolfram, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Muscular Side Effects of Statins

R. Wolfram, H. Sinzinger, B. Peskar, 2002, Journal of cardiovascular pharmacology.

Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer

R. Wolfram, C. Wiltschke, T. Brodowicz, 2000, International journal of cancer.

Brachytherapy and bivalirudin evaluation study.

K. Kent, A. Pichard, L. Satler, 2005, American heart journal.

The proximal location of stenosis in the left anterior descending coronary artery is not a predictive factor of worse outcome in the era of the stent.

A. Pichard, L. Satler, R. Wolfram, 2002, Cardiovascular radiation medicine.

Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up--prospective randomized study.

R. Potter, R. Wolfram, B. Pokrajac, 2006, Radiology.

Endovascular Brachytherapy for Prophylaxis of Restenosis After Femoropopliteal Angioplasty: Results of a Prospective Randomized Study

R Pötter, R. Pötter, R. Wolfram, 2000, Circulation.

Defect of tumour necrosis factor-alpha (TNF-alpha) production and TNF-alpha-induced ICAM-1-expression in BRCA1 mutations carriers.

E. Kubista, R. Wolfram, C. Wiltschke, 2003, Breast cancer research and treatment.

Endovascular brachytherapy in peripheral arteries: Solution for restenosis or false hope?

R. Wolfram, B. Pokrajac, E. Minar, 2003, Current treatment options in cardiovascular medicine.

Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy.

K. Kent, A. Pichard, L. Satler, 2005, Cardiovascular revascularization medicine : including molecular interventions.

Understanding and preventing the edge effect.

R. Wolfram, R. Waksman, L. Leborgne, 2003, Journal of interventional cardiology.

Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosis.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Procedural results and outcomes after extensive stent coverage with drug-eluting stent implantation in single coronary lesions.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Endovascular brachytherapy: effect on acute inflammatory response after percutaneous femoropopliteal arterial interventions.

O. Wagner, R. Wolfram, B. Pokrajac, 2004, Radiology.

Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model.

N. Kipshidze, G. Dangas, J. Moses, 2003, Cardiovascular radiation medicine.

580 Prostate cancer apoptosis in androgen dependent and independent cell cultures harvested from in vivo specimen

M. Marberger, R. Wolfram, B. Djavan, 2004 .

Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery--the Vienna experience.

R. Potter, R. Wolfram, B. Pokrajac, 2005, Radiology.

Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis.

G. Mintz, K. Kent, A. Pichard, 2004, The American journal of cardiology.

Novel site‐specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model

Antonio Colombo, George Dangas, Ron Waksman, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Oral rapamycin inhibits growth of atherosclerotic plaque in apoE knock-out mice.

M. Burnett, R. Wolfram, R. Pakala, 2003, Cardiovascular radiation medicine.

Radioiodine therapy induces dose-dependent in vivo oxidation injury: evidence by increased isoprostane 8-epi-PGF(2 alpha).

R. Wolfram, B. Palumbo, H. Sinzinger, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 multicenter study

C. Kirisits, R. Wolfram, B. Pokrajac, 2003 .

Percutaneous coronary intervention with drug‐eluting stents in octogenarians: Characteristics, clinical presentation, and outcomes

N. Weissman, K. Kent, A. Pichard, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

CORONARY ARTERY DISEASE Original Studies Use of Restenting Should Be Minimized With Intracoronary Radiation Therapy for In-Stent Restenosis

K. Kent, A. Pichard, L. Satler, 2003 .